ByHeart Stock

byheart.comFoodTech / Food Products & ServicesFounded: 2016Funding to Date: $272.12MM

ByHeart is a fully integrated baby nutrition company and developer of a digital platform offering access to resources and education to support parents in their feeding decisions from pregnancy through toddlerdom. Their main product is a clinically-proven, next-to-breast milk, clean ingredient infant formula. The company was founded by Mia Funt and Ron Belldegrun in 2016 and is headquartered in New York, NY.

Register To Buy and Sell Shares

For more details on financing and valuation for ByHeart, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access ByHeart’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like ByHeart.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

ByHeart investors also invested in these private companies


Management Team

Caroline Doyle
Elyssa Dimant
Chief Brand & Communications Officer
Devon Kuehn MD
Chief Medical Officer

Board Members

Ron Belldegrun
Co-Founder, Chief Executive Officer & Board Member
Mia Funt
Co-Founder, President & Board Member
Amy Schulman JD
Polaris Partners
Arie Belldegrun MD
Bellco Capital
Guy Oranim
Board Member
Hemi Zucker
OCV Partners
Josh Bradley JD
Board Member

ByHeart’s stock FAQs


Can you buy ByHeart’s stock?

ByHeart is not publicly traded on NYSE or NASDAQ in the U.S. To buy ByHeart’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell ByHeart’s stock?

Yes, you can sell stock of a private company like ByHeart. Forge can help you sell your ByHeart stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is ByHeart’s stock price?

ByHeart is a privately held company and therefore does not have a public stock price. However, you may access ByHeart’s private market stock price with Forge Data.

What is ByHeart’s stock ticker symbol?

ByHeart does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

ByHeart Baby Formula Review

ByHeart Baby Formula, founded in 2016, uses organic, grass-fed whole milk and a patented protein blend found in breast milk. The formula does not contain corn syrup, soy, or palm oil. The company owns its own manufacturing and research and development. The product is only available on ByHeart's website and costs $39 for a can that makes 46 4-ounce bottles. The company also offers a customizable subscription plan.

ByHeart infant formula makes retail debut at Target locations nationwide

ByHeart's infant formula, made with a patented protein blend similar to breast milk, has begun retail distribution at Target locations across the US. Previously employing a direct-to-consumer model, ByHeart has also announced plans to relaunch product sales on its website later this year. The company claims its formula offers easier digestion for infants and has received the Clean Label Project Purity Award.
Updated on: Jun 24, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.